FDA Inspection 1017789 — Vitalant

Vitalant — FEI 1000143480

The FDA completed an inspection of Vitalant on June 16, 2017 in Aberdeen, SD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Aberdeen, SD (United States)